Anti–vascular Endothelial Growth Factor Therapy Market Report

China Anti–vascular Endothelial Growth Factor Therapy Industry Market Research Report 2023-2029

  • POSTDATE：Sep 10, 2023
  • PAGES：138
  • REPORT CODE：GMM1790530
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Anti–vascular Endothelial Growth Factor Therapy industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Bristol-Myers-Squibb Company

    • Boehringer Ingelheim GmbH

    • Pfizer, Inc

    • Sanofi,

    • GlaxoSmithKline plc

    • Merck & Co, Inc

    • Genentech, Inc (Roche)

    • AstraZeneca plc

    • Novartis AG

    By Type:

    • Avastin

    • Tecentriq

    • Others

    • Cometriq

    • Eylea

    By Application:

    • Ophthalmology

    • Others

    • Oncology

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Anti–vascular Endothelial Growth Factor Therapy Market Overview 2018-2029

    • 1.1 China Anti–vascular Endothelial Growth Factor Therapy Industry Development Overview

    • 1.2 China Anti–vascular Endothelial Growth Factor Therapy Industry Development History

    • 1.3 China Anti–vascular Endothelial Growth Factor Therapy Industry Market Size (2018-2029)

    • 1.4 China Anti–vascular Endothelial Growth Factor Therapy Market Analysis by Type from Production Side

      • 1.4.1 China Anti–vascular Endothelial Growth Factor Therapy Production Volume, Production Value and Growth Rate of Avastin (2018-2029)

      • 1.4.2 China Anti–vascular Endothelial Growth Factor Therapy Production Volume, Production Value and Growth Rate of Tecentriq (2018-2029)

      • 1.4.3 China Anti–vascular Endothelial Growth Factor Therapy Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.4 China Anti–vascular Endothelial Growth Factor Therapy Production Volume, Production Value and Growth Rate of Cometriq (2018-2029)

      • 1.4.5 China Anti–vascular Endothelial Growth Factor Therapy Production Volume, Production Value and Growth Rate of Eylea (2018-2029)

    • 1.5 China Anti–vascular Endothelial Growth Factor Therapy Market Analysis by Application from Consumption End

      • 1.5.1 China Anti–vascular Endothelial Growth Factor Therapy Sales Volume, Sales Value and Growth Rate of Ophthalmology (2018-2029)

      • 1.5.2 China Anti–vascular Endothelial Growth Factor Therapy Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.3 China Anti–vascular Endothelial Growth Factor Therapy Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)

    • 1.6 China Anti–vascular Endothelial Growth Factor Therapy Market Analysis by Region

      • 1.6.1 North China Anti–vascular Endothelial Growth Factor Therapy Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Anti–vascular Endothelial Growth Factor Therapy Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Anti–vascular Endothelial Growth Factor Therapy Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Anti–vascular Endothelial Growth Factor Therapy Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Anti–vascular Endothelial Growth Factor Therapy Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Anti–vascular Endothelial Growth Factor Therapy Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Anti–vascular Endothelial Growth Factor Therapy Market Size and Growth Rate from 2018-2029

    Chapter 2 China Anti–vascular Endothelial Growth Factor Therapy Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Anti–vascular Endothelial Growth Factor Therapy Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Anti–vascular Endothelial Growth Factor Therapy Market Status and Competition Analysis in 2023

      • 2.2.3 China Anti–vascular Endothelial Growth Factor Therapy Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Anti–vascular Endothelial Growth Factor Therapy Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Anti–vascular Endothelial Growth Factor Therapy Industry Development

    Chapter 3 Anti–vascular Endothelial Growth Factor TherapyIndustry Chain Analysis

    • 3.1 Anti–vascular Endothelial Growth Factor Therapy Industry Chain

    • 3.2 Anti–vascular Endothelial Growth Factor Therapy Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Anti–vascular Endothelial Growth Factor Therapy Market

    • 3.3 Anti–vascular Endothelial Growth Factor Therapy Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Anti–vascular Endothelial Growth Factor Therapy Market

    Chapter 4 China Anti–vascular Endothelial Growth Factor Therapy Market, by Type

    • 4.1 China Anti–vascular Endothelial Growth Factor Therapy Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Anti–vascular Endothelial Growth Factor Therapy Total Production Volume and Growth Rate from Production Side

    • 4.5 China Anti–vascular Endothelial Growth Factor Therapy Production Volume and Growth Rate, by Type

      • 4.5.1 China Anti–vascular Endothelial Growth Factor Therapy Production Volume and Growth Rate of Avastin

      • 4.5.2 China Anti–vascular Endothelial Growth Factor Therapy Production Volume and Growth Rate of Tecentriq

      • 4.5.3 China Anti–vascular Endothelial Growth Factor Therapy Production Volume and Growth Rate of Others

      • 4.5.4 China Anti–vascular Endothelial Growth Factor Therapy Production Volume and Growth Rate of Cometriq

      • 4.5.5 China Anti–vascular Endothelial Growth Factor Therapy Production Volume and Growth Rate of Eylea

    Chapter 5 China Anti–vascular Endothelial Growth Factor Therapy Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Anti–vascular Endothelial Growth Factor Therapy Total Market Size and Growth Rate from Consumption End

    • 5.5 China Anti–vascular Endothelial Growth Factor Therapy Market Size and Growth Rate, by Application

      • 5.5.1 China Anti–vascular Endothelial Growth Factor Therapy Market Size and Growth Rate of Ophthalmology

      • 5.5.2 China Anti–vascular Endothelial Growth Factor Therapy Market Size and Growth Rate of Others

      • 5.5.3 China Anti–vascular Endothelial Growth Factor Therapy Market Size and Growth Rate of Oncology

    Chapter 6 China Anti–vascular Endothelial Growth Factor Therapy Market, by Region

    • 6.1 China Anti–vascular Endothelial Growth Factor Therapy Production Volume and Production Value, by Region

    • 6.2 China Anti–vascular Endothelial Growth Factor Therapy Sales Volume and Sales Value, by Region

    Chapter 7 North China Anti–vascular Endothelial Growth Factor Therapy Market Analysis

    • 7.1 North China Anti–vascular Endothelial Growth Factor Therapy Market, by Type

    • 7.2 North China Anti–vascular Endothelial Growth Factor Therapy Market, by Application

    Chapter 8 Central China Anti–vascular Endothelial Growth Factor Therapy Market Analysis

    • 8.1 Central China Anti–vascular Endothelial Growth Factor Therapy Market, by Type

    • 8.2 Central China Anti–vascular Endothelial Growth Factor Therapy Market, by Application

    Chapter 9 South China Anti–vascular Endothelial Growth Factor Therapy Market Analysis

    • 9.1 South China Anti–vascular Endothelial Growth Factor Therapy Market, by Type

    • 9.2 South China Anti–vascular Endothelial Growth Factor Therapy Market, by Application

    Chapter 10 East China Anti–vascular Endothelial Growth Factor Therapy Market Analysis

    • 10.1 East China Anti–vascular Endothelial Growth Factor Therapy Market, by Type

    • 10.2 East China Anti–vascular Endothelial Growth Factor Therapy Market, by Application

    Chapter 11 Northeast China Anti–vascular Endothelial Growth Factor Therapy Market Analysis

    • 11.1 Northeast China Anti–vascular Endothelial Growth Factor Therapy Market, by Type

    • 11.2 Northeast China Anti–vascular Endothelial Growth Factor Therapy Market, by Application

    Chapter 12 Southwest China Anti–vascular Endothelial Growth Factor Therapy Market Analysis

    • 12.1 Southwest China Anti–vascular Endothelial Growth Factor Therapy Market, by Type

    • 12.2 Southwest China Anti–vascular Endothelial Growth Factor Therapy Market, by Application

    Chapter 13 Northwest China Anti–vascular Endothelial Growth Factor Therapy Market Analysis

    • 13.1 Northwest China Anti–vascular Endothelial Growth Factor Therapy Market, by Type

    • 13.2 Northwest China Anti–vascular Endothelial Growth Factor Therapy Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Bristol-Myers-Squibb Company

        • 14.1.1 Bristol-Myers-Squibb Company Company Profile

        • 14.1.2 Bristol-Myers-Squibb Company Anti–vascular Endothelial Growth Factor Therapy Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Boehringer Ingelheim GmbH

        • 14.2.1 Boehringer Ingelheim GmbH Company Profile

        • 14.2.2 Boehringer Ingelheim GmbH Anti–vascular Endothelial Growth Factor Therapy Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Pfizer, Inc

        • 14.3.1 Pfizer, Inc Company Profile

        • 14.3.2 Pfizer, Inc Anti–vascular Endothelial Growth Factor Therapy Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Sanofi,

        • 14.4.1 Sanofi, Company Profile

        • 14.4.2 Sanofi, Anti–vascular Endothelial Growth Factor Therapy Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 GlaxoSmithKline plc

        • 14.5.1 GlaxoSmithKline plc Company Profile

        • 14.5.2 GlaxoSmithKline plc Anti–vascular Endothelial Growth Factor Therapy Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Merck & Co, Inc

        • 14.6.1 Merck & Co, Inc Company Profile

        • 14.6.2 Merck & Co, Inc Anti–vascular Endothelial Growth Factor Therapy Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Genentech, Inc (Roche)

        • 14.7.1 Genentech, Inc (Roche) Company Profile

        • 14.7.2 Genentech, Inc (Roche) Anti–vascular Endothelial Growth Factor Therapy Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 AstraZeneca plc

        • 14.8.1 AstraZeneca plc Company Profile

        • 14.8.2 AstraZeneca plc Anti–vascular Endothelial Growth Factor Therapy Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Novartis AG

        • 14.9.1 Novartis AG Company Profile

        • 14.9.2 Novartis AG Anti–vascular Endothelial Growth Factor Therapy Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Anti–vascular Endothelial Growth Factor Therapy Industry Research Conclusions

    • 15.2 Anti–vascular Endothelial Growth Factor Therapy Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Anti–vascular Endothelial Growth Factor Therapy Industry Market Size (2018-2029)

    • Figure China Anti–vascular Endothelial Growth Factor Therapy Production Volume, Production Value and Growth Rate of Avastin (2018-2029)

    • Figure China Anti–vascular Endothelial Growth Factor Therapy Production Volume, Production Value and Growth Rate of Tecentriq (2018-2029)

    • Figure China Anti–vascular Endothelial Growth Factor Therapy Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Anti–vascular Endothelial Growth Factor Therapy Production Volume, Production Value and Growth Rate of Cometriq (2018-2029)

    • Figure China Anti–vascular Endothelial Growth Factor Therapy Production Volume, Production Value and Growth Rate of Eylea (2018-2029)

    • Figure China Anti–vascular Endothelial Growth Factor Therapy Sales Volume, Sales Value and Growth Rate of Ophthalmology (2018-2029)

    • Figure China Anti–vascular Endothelial Growth Factor Therapy Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Anti–vascular Endothelial Growth Factor Therapy Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)

    • Figure North China Anti–vascular Endothelial Growth Factor Therapy Market Size and Growth Rate from 2018-2029

    • Figure Central China Anti–vascular Endothelial Growth Factor Therapy Market Size and Growth Rate from 2018-2029

    • Figure South China Anti–vascular Endothelial Growth Factor Therapy Market Size and Growth Rate from 2018-2029

    • Figure East China Anti–vascular Endothelial Growth Factor Therapy Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Anti–vascular Endothelial Growth Factor Therapy Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Anti–vascular Endothelial Growth Factor Therapy Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Anti–vascular Endothelial Growth Factor Therapy Market Size and Growth Rate from 2018-2029

    • Figure Anti–vascular Endothelial Growth Factor Therapy Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Anti–vascular Endothelial Growth Factor Therapy Market Share by Type in 2018

    • Figure China Anti–vascular Endothelial Growth Factor Therapy Market Share by Type in 2023

    • Figure China Anti–vascular Endothelial Growth Factor Therapy Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Anti–vascular Endothelial Growth Factor Therapy Production Volume and Growth Rate of Avastin (2018-2023)

    • Figure China Anti–vascular Endothelial Growth Factor Therapy Production Volume and Growth Rate of Tecentriq (2018-2023)

    • Figure China Anti–vascular Endothelial Growth Factor Therapy Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Anti–vascular Endothelial Growth Factor Therapy Production Volume and Growth Rate of Cometriq (2018-2023)

    • Figure China Anti–vascular Endothelial Growth Factor Therapy Production Volume and Growth Rate of Eylea (2018-2023)

    • Figure China Anti–vascular Endothelial Growth Factor Therapy Market Share by Application in 2018

    • Figure China Anti–vascular Endothelial Growth Factor Therapy Market Share by Application in 2023

    • Figure China Anti–vascular Endothelial Growth Factor Therapy Total Market Size and Growth Rate from Consumption End

    • Figure China Anti–vascular Endothelial Growth Factor Therapy Market Size and Growth Rate of Ophthalmology (2018-2023)

    • Figure China Anti–vascular Endothelial Growth Factor Therapy Market Size and Growth Rate of Others (2018-2023)

    • Figure China Anti–vascular Endothelial Growth Factor Therapy Market Size and Growth Rate of Oncology (2018-2023)

    • Table China Anti–vascular Endothelial Growth Factor Therapy Production Volume by Region (2018-2023)

    • Table China Anti–vascular Endothelial Growth Factor Therapy Production Volume Share by Region (2018-2023)

    • Figure China Anti–vascular Endothelial Growth Factor Therapy Production Volume Share by Region (2018-2023)

    • Table China Anti–vascular Endothelial Growth Factor Therapy Production Value by Region (2018-2023)

    • Table China Anti–vascular Endothelial Growth Factor Therapy Production Value Share by Region (2018-2023)

    • Figure China Anti–vascular Endothelial Growth Factor Therapy Production Value Share by Region (2018-2023)

    • Table China Anti–vascular Endothelial Growth Factor Therapy Sales Volume by Region (2018-2023)

    • Table China Anti–vascular Endothelial Growth Factor Therapy Sales Volume Share by Region (2018-2023)

    • Figure China Anti–vascular Endothelial Growth Factor Therapy Sales Volume Share by Region (2018-2023)

    • Table China Anti–vascular Endothelial Growth Factor Therapy Sales Value by Region (2018-2023)

    • Table China Anti–vascular Endothelial Growth Factor Therapy Sales Value Share by Region (2018-2023)

    • Figure China Anti–vascular Endothelial Growth Factor Therapy Sales Value Share by Region (2018-2023)

    • Table North China Anti–vascular Endothelial Growth Factor Therapy Production Volume by Type (2018-2023)

    • Table North China Anti–vascular Endothelial Growth Factor Therapy Production Volume Share by Type (2018-2023)

    • Figure North China Anti–vascular Endothelial Growth Factor Therapy Production Volume Share by Type (2018-2023)

    • Table North China Anti–vascular Endothelial Growth Factor Therapy Sales Volume by Application (2018-2023)

    • Table North China Anti–vascular Endothelial Growth Factor Therapy Sales Volume Share by Application (2018-2023)

    • Figure North China Anti–vascular Endothelial Growth Factor Therapy Sales Volume Share by Application (2018-2023)

    • Table Central China Anti–vascular Endothelial Growth Factor Therapy Production Volume by Type (2018-2023)

    • Table Central China Anti–vascular Endothelial Growth Factor Therapy Production Volume Share by Type (2018-2023)

    • Figure Central China Anti–vascular Endothelial Growth Factor Therapy Production Volume Share by Type (2018-2023)

    • Table Central China Anti–vascular Endothelial Growth Factor Therapy Sales Volume by Application (2018-2023)

    • Table Central China Anti–vascular Endothelial Growth Factor Therapy Sales Volume Share by Application (2018-2023)

    • Figure Central China Anti–vascular Endothelial Growth Factor Therapy Sales Volume Share by Application (2018-2023)

    • Table South China Anti–vascular Endothelial Growth Factor Therapy Production Volume by Type (2018-2023)

    • Table South China Anti–vascular Endothelial Growth Factor Therapy Production Volume Share by Type (2018-2023)

    • Figure South China Anti–vascular Endothelial Growth Factor Therapy Production Volume Share by Type (2018-2023)

    • Table South China Anti–vascular Endothelial Growth Factor Therapy Sales Volume by Application (2018-2023)

    • Table South China Anti–vascular Endothelial Growth Factor Therapy Sales Volume Share by Application (2018-2023)

    • Figure South China Anti–vascular Endothelial Growth Factor Therapy Sales Volume Share by Application (2018-2023)

    • Table East China Anti–vascular Endothelial Growth Factor Therapy Production Volume by Type (2018-2023)

    • Table East China Anti–vascular Endothelial Growth Factor Therapy Production Volume Share by Type (2018-2023)

    • Figure East China Anti–vascular Endothelial Growth Factor Therapy Production Volume Share by Type (2018-2023)

    • Table East China Anti–vascular Endothelial Growth Factor Therapy Sales Volume by Application (2018-2023)

    • Table East China Anti–vascular Endothelial Growth Factor Therapy Sales Volume Share by Application (2018-2023)

    • Figure East China Anti–vascular Endothelial Growth Factor Therapy Sales Volume Share by Application (2018-2023)

    • Table Northeast China Anti–vascular Endothelial Growth Factor Therapy Production Volume by Type (2018-2023)

    • Table Northeast China Anti–vascular Endothelial Growth Factor Therapy Production Volume Share by Type (2018-2023)

    • Figure Northeast China Anti–vascular Endothelial Growth Factor Therapy Production Volume Share by Type (2018-2023)

    • Table Northeast China Anti–vascular Endothelial Growth Factor Therapy Sales Volume by Application (2018-2023)

    • Table Northeast China Anti–vascular Endothelial Growth Factor Therapy Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Anti–vascular Endothelial Growth Factor Therapy Sales Volume Share by Application (2018-2023)

    • Table Southwest China Anti–vascular Endothelial Growth Factor Therapy Production Volume by Type (2018-2023)

    • Table Southwest China Anti–vascular Endothelial Growth Factor Therapy Production Volume Share by Type (2018-2023)

    • Figure Southwest China Anti–vascular Endothelial Growth Factor Therapy Production Volume Share by Type (2018-2023)

    • Table Southwest China Anti–vascular Endothelial Growth Factor Therapy Sales Volume by Application (2018-2023)

    • Table Southwest China Anti–vascular Endothelial Growth Factor Therapy Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Anti–vascular Endothelial Growth Factor Therapy Sales Volume Share by Application (2018-2023)

    • Table Northwest China Anti–vascular Endothelial Growth Factor Therapy Production Volume by Type (2018-2023)

    • Table Northwest China Anti–vascular Endothelial Growth Factor Therapy Production Volume Share by Type (2018-2023)

    • Figure Northwest China Anti–vascular Endothelial Growth Factor Therapy Production Volume Share by Type (2018-2023)

    • Table Northwest China Anti–vascular Endothelial Growth Factor Therapy Sales Volume by Application (2018-2023)

    • Table Northwest China Anti–vascular Endothelial Growth Factor Therapy Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Anti–vascular Endothelial Growth Factor Therapy Sales Volume Share by Application (2018-2023)

    • Table Bristol-Myers-Squibb Company Company Profile

    • Table Bristol-Myers-Squibb Company Anti–vascular Endothelial Growth Factor Therapy Revenue, Price and Gross (2018-2023)

    • Table Boehringer Ingelheim GmbH Company Profile

    • Table Boehringer Ingelheim GmbH Anti–vascular Endothelial Growth Factor Therapy Revenue, Price and Gross (2018-2023)

    • Table Pfizer, Inc Company Profile

    • Table Pfizer, Inc Anti–vascular Endothelial Growth Factor Therapy Revenue, Price and Gross (2018-2023)

    • Table Sanofi, Company Profile

    • Table Sanofi, Anti–vascular Endothelial Growth Factor Therapy Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline plc Company Profile

    • Table GlaxoSmithKline plc Anti–vascular Endothelial Growth Factor Therapy Revenue, Price and Gross (2018-2023)

    • Table Merck & Co, Inc Company Profile

    • Table Merck & Co, Inc Anti–vascular Endothelial Growth Factor Therapy Revenue, Price and Gross (2018-2023)

    • Table Genentech, Inc (Roche) Company Profile

    • Table Genentech, Inc (Roche) Anti–vascular Endothelial Growth Factor Therapy Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca plc Company Profile

    • Table AstraZeneca plc Anti–vascular Endothelial Growth Factor Therapy Revenue, Price and Gross (2018-2023)

    • Table Novartis AG Company Profile

    • Table Novartis AG Anti–vascular Endothelial Growth Factor Therapy Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US